MCapMediaWire -- Freedom Holdings, Inc. (OTC: FHLD) (“FHLD” or the "Company”), is pleased to announce that it has entered into a Definitive Agreement that will change the control and operations of the Company to MEDcann Industries, Inc. MEDcann is going to modify the forward direction of Freedom to include topical and organic natural Marijuana plant-based products (OTC) “over the counter” entering the Cannabis health care products market in which the Company management believes will boost shareholder value.
Freedom Holdings management will bring the companies platforms to a new level to be current with all SEC, OTC and FINRA requirements, publishing its 2022-year end Information and Statements to bring the company current and re-structuring the company with a productive reorganization. The will allow the Company to negotiate with private companies in the Cannabis industry specifically looking for beverage, cosmetics, vitamin, and medicinal companies to acquire and or joint venture with.
Under the terms of the agreement,
- MEDcann is to purchase 40,000,000 restricted shares from the Company for $50,000.00 (.00125 per share) representing the 80% ownership of the Company and
- Brian Kistler shall resign all Officer/Director positions only to serve as an advisor for a period of 2 years to insure a smooth transition and
- John Vivian, CEO of MEDcann shall simultaneously be appointed as the Chairman and CEO of Freedom and
- MEDcann as the parent company shall assume the debt and ongoing operational costs of Freedom
- All financial disclosures are to be brought current
The Closing of the conditions as outlined, Freedom has become a majority owned subsidiary of MEDcann with operations of MEDcann Industries to be transferred into Freedom for future development.
About MEDcann Industries, Inc.
MEDcann Industries, Inc. was founded in Februsry 2020 to create and develop a high-quality worldwide Distribution, Research and Manufacturing Facility. Investigating the resources, we found many different types of products and plan to be one of the competitive manufactures and marketers. We intend to manufacture and assemble everything from Medicine, Cosmetic to Health treatment products and drinks. For more information regarding MEDcann please visit https://MEDcannindustries.com/
Press Release Contact:
Brian Kistler
CEO
Freedom Holdings, Inc.
260-490-9990
John Vivian
CEO
MEDcann Industries, Inc
813-699-4098
Safe Harbor Statement
This press release contains statements, which may constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief, or current expectations of the Company, members of its management, and assumptions on which such statements are based. We caution prospective investors that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements.
Contact Details
Freedom Holdings, Inc.
Brian Kistler
+1 260-490-9990
MEDcann Industries, Inc
John Vivian
+1 813-699-4098
